Long-term outcome of adult acute lymphoblastic leukemia in Lebanon: a single institution experience from the American University of Beirut

Hematology/oncology and Stem Cell Therapy
Khalil M CharafeddineAli Bazarbachi

Abstract

The most important studies about outcome of acute leukemia come from developed countries, whereas most of the patients with this disease are in developing countries. We report predictive and prognostic factors in patients with acute lymphoblastic leukemia (ALL) in a tertiary care center in a developing country. We retrospectively reviewed the records of adult patients with acute leukemia who were referred to the American University of Beirut Medical Center between 1996 and early 2006. Of 105 patients, 36 (34%) patients were diagnosed with ALL, and included 19 (53%) males and 17 (47%) females with a median age of 34 years (range, 14-79 years). Induction chemotherapy with curative intent was administered to 34 (94%) patients. Twenty-seven patients received intrathecal chemotherapy as prophylaxis (n=24) or as treatment for CNS disease (n=3). Twenty-eight patients (82%) achieved complete remission (CR) after induction chemotherapy. The median overall survival (OS) time was 22 months and the five-year OS for ALL patients was 38%. The median disease-free survival (DFS) time was 12 months, while the five-year DFS was 38%. Multivariate analysis showed that age <40 years, WBC <30 X 109/L, achievement of CR after first induction, and CNS...Continue Reading

References

Jan 9, 2001·Hematology/oncology Clinics of North America·I J DurrantA H Goldstone
Oct 23, 2002·The Hematology Journal : the Official Journal of the European Haematology Association·Luciana AnninoAndré Delannoy
Aug 13, 2003·Hematology·Xavier Thomas, Quoc-Hung Le
Feb 21, 2004·CA: a Cancer Journal for Clinicians·Ahmedin JemalUNKNOWN American Cancer Society
Jan 13, 2006·The New England Journal of Medicine·Ching-Hon Pui, William E Evans
Mar 4, 2006·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Sep 19, 2006·European Journal of Haematology·Quoc-Hung LeDenis Fiere
Oct 5, 2006·Cancer·Barbara Deschler, Michael Lübbert
Nov 25, 2006·Hematology·Nicola Gökbuget, Dieter Hoelzer
Dec 21, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·André SchrauderMartin Schrappe

❮ Previous
Next ❯

Citations

Nov 9, 2010·Leukemia & Lymphoma·Guillermo J Ruiz-DelgadoGuillermo J Ruiz-Argüelles
Oct 27, 2018·Journal of Cellular Biochemistry·Nashwa El-KhazragyMenha Swellam
Apr 20, 2021·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Dyna Jaza MohammedNasir Abdulsalam Al-Allawi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
G F ArajG W Jamaleddine
Middle East Journal of Anesthesiology
Fouad Salim Haddad, M Muallem
The Johns Hopkins Medical Journal
S P Asper, J M Neff
JAMA : the Journal of the American Medical Association
W M Bickers
© 2021 Meta ULC. All rights reserved